证券之星消息,新华制药2025年一季报显示,公司主营收入24.3亿元,同比下降1.81%;归母净利润1.12亿元,同比下降20.99%;扣非净利润1.05亿元,同比下降23.74%;负债率41.86%,投资收益-76.02万元,财务费用403.52万元,毛利率18.75%。财报数据概要请见下图:
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.